799557-82-7 Usage
Chemical class
1-Piperazinecarboxylic acid, 3-methyl-4-(1-methylethyl)-, phenylmethyl ester, (3S)is a chemical compound belonging to the piperazine class.
Derivative
It is a phenylmethyl ester derivative of 1-piperazinecarboxylic acid.
Stereochemistry
The compound has a (3S)stereochemistry.
Pharmaceutical applications
The compound has potential pharmaceutical applications due to its properties.
Central nervous system stimulant
It has the potential to act as a central nervous system stimulant.
Analgesic properties
The compound may possess analgesic (pain-relieving) properties.
Anti-inflammatory properties
It may also have anti-inflammatory properties.
Medication development
Due to its structural features, it may be of interest in the development of new medications for pain relief, neurological disorders, or inflammation.
Further research needed
More research and studies are required to fully understand its potential pharmacological properties and applications.
Check Digit Verification of cas no
The CAS Registry Mumber 799557-82-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,9,9,5,5 and 7 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 799557-82:
(8*7)+(7*9)+(6*9)+(5*5)+(4*5)+(3*7)+(2*8)+(1*2)=257
257 % 10 = 7
So 799557-82-7 is a valid CAS Registry Number.
799557-82-7Relevant academic research and scientific papers
PYRROLIDINE DERIVATIVES AS HISTAMINE RECEPTORS LIGANDS
-
Page/Page column 28, (2010/11/08)
The present invention relates to pyrrolidine derivatives of formula (I) having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of neurological and psychiatric disorders.
PIPERAZINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISEASES
-
Page 26, (2008/06/13)
The present invention relates to novel piperidine carbonyl piperazine derivatives having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of neurological and psychiatric disorders.
